InvestorsHub Logo
Followers 4
Posts 326
Boards Moderated 0
Alias Born 10/19/2005

Re: Solantey post# 23020

Sunday, 12/23/2012 11:54:12 PM

Sunday, December 23, 2012 11:54:12 PM

Post# of 130507
Solantey is right going to $1.00 or more.

FYI: We will just keep responding to your bullish comments to show people your true colors


"Big pharma" development partnership(s) or buyout in 2013.

$1.00 or more.

Major drug companies have billions of dollars to spend on acquisitions or partnerships.

AMBS is the most undervalued bio-tech in the market.

.20-.25 by 12/31/2012.

The co-founder of Amgen is 100% correct when he stated that the company's MANF technology would be worth billions and be a blockbuster drug.